S. 3302In Committee
Mikaela Naylon Give Kids a Chance Act of 2025
Authorizes combination drug trials for pediatric cancer and extends the rare pediatric disease priority review voucher program through September 30, 2030
Plain-English overview
What this bill does
Authorizes combination drug trials for pediatric cancer and extends the rare pediatric disease priority review voucher program through September 30, 2030
Key points
- Require GAO effectiveness reports
- Direct FDA implementation guidance
- Modify pediatric cancer trial requirements
- Extend rare pediatric disease vouchers
Current status
Where it stands
Status
In Committee
Latest action
2025-12-02 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related context
Topics and policy areas
undefinedHealth